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EDITORIAL
In the Journal’s editorial of March 2019, I alluded to the pressing 
and broad (no pun intended) issue of gender inequality in 
the domain of leadership representation in Endocrinology. 
It would seem that poor representation is also prevalent in 
the value which allied disciplines offer and the integrated and 
multidisciplinary approach to patient care is often overlooked. 
While the Journal continues to strive to attract “cutting edge” 
submissions, it should also offer wider comment appropriate 
to (usually lack of ) involvement and from (more assertive input) 
allied disciplines. This is especially relevant in the context of 
healthcare delivery in developing countries where both doctor 
shortage and concomitant task shifting amongst healthcare 
personnel is often the norm.  
As such, Manickum P et al remind us (sadly enough) that 
patients with diabetes mellitus account for half the lower limb 
amputations in South Africa and with a five-year audit, less 
than 20% of amputees were referred for rehabilitation (even 
more sadly) – this is a crippling (again no pun intended) lapse 
of treatment. 
 Kaplan H et al provide very comprehensive data on 
hypoglycaemia in 445 treated patients with T1 and T2 diabetes. 
The high frequency of hypoglycaemic episodes (77% in T1 and 
18% in T2 patients) and the frequency of severe hypoglycaemia 
(22% in T1 and 5% in T2 patients) over a three-month period 
are noteworthy. Reference is made to the doctor team (29 GPs 
and nine specialists) involved but perhaps too little emphasis 
was placed on allied team involvement (nurse educators and 
pharmacists) in regards to patient education (especially relevant 
with insulin and sulphonylurea medications). 
Magnesium deficiency is known to correlate with diabetes. 
Jansen van Vuuren J et al offer a viewpoint on their observed 
correlation between serum magnesium and lipid subsets in 
a cohort of South Africans with diabetes. It would seem that 
magnesium supplementation may potentially impact adversely 
on lipid fractions in certain ethnic (vulnerable) groups and as 
such, supplementation should be utilised with caution. 
Lifestyle change remains a cornerstone of therapy in patients 
with diabetes. This is especially relevant in overweight/obese 
patients with T2 disease, where an appropriate exercise 
programme may reduce insulin resistance significantly. Thaane T 
et al review the specific mechanisms and benefits of supervised 
resistance exercise training programmes. It would suggest that 
such patients with diabetes may deserve the long-term input of 
a biokinetic team. 
Pharmacovigilance is certainly useful and du Plessis J et al 
indicate that testosterone replacement therapy is associated 
with new-onset and significant polycythaemia. This is more 
apparent when therapeutic serum levels of testosterone are 
achieved. These observational data while, not clarifying the 
relationship(s) between testosterone treatment and more or 
fewer cardiovascular events, certainly alerts clinicians to monitor 
this adverse effect especially in a patient at risk for thrombotic 
events. 
There is important and frequent interplay between body 
composition (lean and fat mass), bone mineral density and 
osteopenia-osteoporosis in HIV-treated patients. Ellis C et al, in 
their secondary analysis, indicate these associations. Thus, apart 
from inflammation (bad for bones) and anti-viral medications 
(good and bad for bones) other factors, especially age of the 
patient, emerge as important risk factor(s) in this dynamic.    
Happy reading,
Jeff Wing
